A new national survey of Canadian adults reveals significant gaps in understanding of shingles risk factors and a lack of concern among those most at risk of the viral infection. The survey also found ...

Patent strengthens CVC's leading position in European CRISPR IP landscape, providing security to over 150 ERS Genomics licensees. DUBLIN and CHESTER, England, Feb. 26, 2025 /PRNew ...

US net sales, recognized by Viatris, reached an all-time high of $66.7 million in Q4 2024 and $238.6 million in FY 2024, up 10% and 8%, respectively ...

The list extends into the pharma industry, including Pfizer, GSK, and Novo Nordisk. On 14 November, Eli Lilly became a part of this group, after an account using its name and logo sent out a Tweet ...

Clinical Trials Begin This Month, New Vaccine Targeted for 2021 Medicago and GSK plan to begin a Phase 1 clinical trial ... Flourish enters the Bay Area market with the deal. Flourish Research logo ...

Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE:GSK) between February 5, 2020 and August 14, 2022, both dates inclusive ...

Bank of New York Mellon Corp grew its position in GSK plc (NYSE:GSK – Free Report) by 2.2% during the fourth quarter, HoldingsChannel reports. The firm owned 974,051 shares of the pharmaceutical ...

Feb 14 (Reuters) - Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK (GSK.L), opens new tab, the Financial Times reported on Friday. Citadel has ...

Additionally, GSK's new 5-in-1 meningitis vaccine, Penmenvy, received approval from the US FDA, offering protection against five common serogroups of Neisseria meningitidis for individuals aged 10 ...